APA

Lamfers M. L. M., Grimbergen J. M., Aalders M. C., Havenga M. J., de Vries M. R., Huisman L. G. M., van Hinsbergh V. W. M. & Quax P. H. A. (20021205). Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. : Circulation research.

Chicago

Lamfers M L M, Grimbergen J M, Aalders M C, Havenga M J, de Vries M R, Huisman L G M, van Hinsbergh V W M and Quax P H A. 20021205. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. : Circulation research.

Harvard

Lamfers M. L. M., Grimbergen J. M., Aalders M. C., Havenga M. J., de Vries M. R., Huisman L. G. M., van Hinsbergh V. W. M. and Quax P. H. A. (20021205). Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. : Circulation research.

MLA

Lamfers M L M, Grimbergen J M, Aalders M C, Havenga M J, de Vries M R, Huisman L G M, van Hinsbergh V W M and Quax P H A. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. : Circulation research. 20021205.